Skip to main content
OpenTrials
Completed

NCT Number: NCT03800329

Remote Monitoring to Improve Physician Monitoring, Patient Satisfaction, and Predict Readmissions Following Surgery

This study is designed to determine the perceived value of continuous remote monitoring to surgeons and surgical patients at Mayo Clinic in Rochester, MN, and determine whether algorithms can be generated to predict risk of readmission following discharge. This initial study will be conducted through the Department of Cardiovascular Surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

About this study

The overall aim of this project is to determine the perceived utility and benefit to use of remote monitoring technology in patients being discharged following cardiac surgery at Mayo Clinic in Rochester, MN. The investigators also aim to determine whether machine learning algorithms can predict readmission following cardiac surgery in these patients, which the investigators believe will benefit patients in future studies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Target accrual: 100 patients

Subject population (children, adults, groups): adults undergoing coronary bypass surgery at Mayo Clinic in Rochester, MN

Inclusion criteria

  • Patients undergoing isolated coronary artery bypass graft (CABG) surgery
  • Must be undergoing the procedure at Mayo Clinic in Rochester, MN
  • Must be greater than or equal to 40 years of age

Exclusion criteria

  • Under 40 years of age
  • Concomitant additional surgical procedure (e.g., CABG + valve replacement)
  • Patients with implantable pacemakers/defibrillators
  • Patients that find the device too uncomfortable to wear for 48 hours

Treatment and study plan

Snap40 Monitor

Device

Non-invasive, wearable armband device used to measure change in systolic blood pressure, respiratory rate, heart rate, body temperature, movement, and oxyhemoglobin saturation and streams this information to a cloud-based storage system. Patients will complete a questionnaire.

No Monitor

Other

Patients will be discharged in the ordinary manner, without the Snap40 monitor. Patients will complete a questionnaire.

Primary outcomes

  1. Physician satisfaction in the use of remote monitoring technology.

    Time frame: 48 hours

    Physician satisfaction survey measure the utility and benefit to the use of remote monitoring technology in patients being discharged following cardiac surgery at Mayo Clinic in Rochester, MN.

Secondary outcomes

  1. Patient satisfaction in the use of remote monitoring technology.

    Time frame: 48 hours

    Patient satisfaction survey measures the utility and benefit to the use of remote monitoring technology in patients being discharged following cardiac surgery at Mayo Clinic in Rochester, MN.

Other outcomes

  1. Algorithms useful in prediction of readmission following cardiac surgery

    Time frame: 48 hours

    Measure data collected via machine learning algorithms to predict readmission following cardiac surgery in patients.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Snap40 Ltd.

Registry information

Official study title

Use of Remote Monitoring to Improve Physician Monitoring, Patient Satisfaction, and Predict Readmissions Following Cardiac Surgery

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Jan 11, 2019
Registry last updated
Nov 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.